We next examined the aging dynamics of CpH in our cohort of older adults (54–105-years-old), focusing on 3,661 CpH methylation sites across 848 enhancers found most relevant to AD in the epigenetic and transcriptomic integration analysis (Fig. 3). Here, CPE is linked to Alzheimer disease.